Overview
CareCloud Q3 revenue rises 9% yr/yr, beating analyst expectations
Company raises full-year 2025 revenue guidance to $117-$119 mln
CareCloud completes Medsphere acquisition, accelerates AI initiatives
Outlook
CareCloud raises full-year 2025 revenue guidance to $117-$119 mln
Company expects full-year 2025 adjusted EBITDA of $26-$28 mln
CareCloud projects full-year 2025 EPS of $0.10-$0.13
Result Drivers
ACQUISITIONS - Completion of Medsphere acquisition and others contributed to revenue growth and market expansion
AI INITIATIVES - AI integration into platforms enhanced performance and opened new sales opportunities
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q3 Revenue | Beat | $31.10 mln | $28.62 mln (3 Analysts) |
Q3 EPS | $0.04 | ||
Q3 Adjusted Net Income | $4.40 mln | ||
Q3 Adjusted EBITDA | $7.70 mln |
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the software peer group is "buy"
Wall Street's median 12-month price target for CareCloud Inc is $6.00, about 50.8% above its November 5 closing price of $2.95
The stock recently traded at 22 times the next 12-month earnings vs. a P/E of 18 three months ago
Press Release: ID:nGNXbSFQC5
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)